Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs CPB✓SelectedUSD · CPBGSK vs CPB performance historyLatest closeAs of-2.32%11/17
Stock and ETF performance explorer

GSK vs CPB

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+103.1%
CPB return
-37.7%
Excess return
+140.7%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioCPBExcessAlpha
1D-2.3%+0.6%-2.9%-2.4%
7D-3.0%+4.4%-7.4%-3.8%
30D+0.4%+18.7%-18.3%-2.8%
3M-1.2%+5.3%-6.5%-2.4%
6M+0.9%+21.4%-20.4%-3.0%
YTD+4.0%-10.0%+14.0%+5.1%
1Y+7.3%-18.4%+25.7%+10.3%
3Y+57.1%-33.8%+90.8%+66.5%
5Y+43.0%-30.7%+73.6%+49.3%
10Y+103.1%-37.8%+140.9%+99.5%
All+103.1%-37.7%+140.7%+99.5%

Cumulative growth

Daily Returns

Daily percentage return beside CPB.

Daily Out/Under-Performance

Portfolio return minus CPB return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CPB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded CPB wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling